Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Amortization of Deferred Charges (2020 - 2025)

Historic Amortization of Deferred Charges for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to $399000.0.

  • Maravai Lifesciences Holdings' Amortization of Deferred Charges fell 4708.22% to $399000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year decrease of 3596.11%. This contributed to the annual value of $2.9 million for FY2024, which is 112.67% down from last year.
  • As of Q3 2025, Maravai Lifesciences Holdings' Amortization of Deferred Charges stood at $399000.0, which was down 4708.22% from $391000.0 recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Amortization of Deferred Charges registered a high of $754000.0 during Q3 2024, and its lowest value of $391000.0 during Q2 2025.
  • Moreover, its 5-year median value for Amortization of Deferred Charges was $711000.0 (2022), whereas its average is $658764.7.
  • Per our database at Business Quant, Maravai Lifesciences Holdings' Amortization of Deferred Charges tumbled by 9655.83% in 2021 and then surged by 1360.86% in 2023.
  • Quarter analysis of 5 years shows Maravai Lifesciences Holdings' Amortization of Deferred Charges stood at $681000.0 in 2021, then decreased by 3.96% to $654000.0 in 2022, then grew by 13.61% to $743000.0 in 2023, then decreased by 11.44% to $658000.0 in 2024, then tumbled by 39.36% to $399000.0 in 2025.
  • Its Amortization of Deferred Charges stands at $399000.0 for Q3 2025, versus $391000.0 for Q2 2025 and $461000.0 for Q1 2025.